AlphaFold news
The latest AlphaFold news, : Isomorphic Labs aims to design cancer drugs with AI, plans human trials soon.
AlphaFold is DeepMind’s AI system that predicts protein structures, having generated predictions for more than 200 million proteins and providing a large data foundation for drug‑discovery efforts. Recent coverage highlights its expansion into rare‑disease drug discovery, debates over its scientific limits, inclusion in a new Ohio State‑Google research hub, and industry data‑sharing initiatives aimed at improving protein‑folding models.
10 stories mentioning AlphaFold since 25 September 2026, newest first, each with its sources and discussion. Follow to see new ones on your front page.
-
Isomorphic Labs aims to design cancer drugs with AI, plans human trials soon
Google DeepMind spinoff Isomorphic Labs, led by CEO Demis Hassabis and President Max Jaderberg, is using its AlphaFold-derived drug design engine to develop novel cancer, immune, and inflammatory disease treatments.…
1 sourcebusinessinsider.com -
Medical AI expands into rare‑disease drug discovery and virtual lab markets
DeepMind’s AlphaFold has predicted more than 200 million protein structures, giving AI‑driven drug discovery startups a large data foundation. Recursion Pharmaceuticals, a US biotech, reports encouraging Phase 1b/2…
1 sourceUnite.AI -
Google DeepMind’s Antigravity finds novel antimicrobial peptide candidate
Google DeepMind published a technical walkthrough on October 15, 2026, detailing how its agentic platform, Antigravity, helped researchers identify a new antimicrobial peptide candidate in Streptococcus…
1 sourceUnite.AI -
DeepMind and Biohub debate AlphaFold’s limits in protein folding
Google DeepMind’s Pushmeet Kohli and Biohub’s Sal Candido discussed why AlphaFold’s breakthrough in protein structure prediction did not fully solve biology’s challenges. They argued that scaling compute and data alone…
1 sourceLatent Space -
DeepMind’s Lila Ibrahim discusses AI’s role in science and accessibility
Lila Ibrahim, Google DeepMind’s Chief AI Readiness Officer, spoke on CNBC’s Changemakers podcast about how AI can advance science, education, and accessibility—while emphasizing the need for responsible development. In…
2 sourcescnbc.com -
Microsoft Research unveils Quine, a biological world model for life sciences
Microsoft Research has announced Quine, a new AI system designed to function as a 'biological world model.' Unlike specialized models that handle only proteins or gene data, Quine integrates diverse biological…
1 sourcenote.com -
Ohio State and Google launch AI research hub with DeepMind models and Gemini access
Ohio State University and Google announced a five-year partnership on September 29, 2026, to create an on-campus AI research hub in Ohio State’s Innovation District. The collaboration includes access to Google…
1 sourcefinance.yahoo.com -
AI may narrow scientific exploration, authors argue
A new opinion piece in Nature Machine Learning argues that while AI boosts individual researcher productivity, it is narrowing the scope of scientific inquiry. The authors note that academics using AI tools publish…
1 source primary sourceNature Machine Learning -
Kurumi WEB X launches AI-powered note studios with Google DeepMind’s Moana
Kurumi WEB X, a new lab inspired by Google X’s moonshot culture, introduced three AI-powered studios—Note Title & Structure Creation, Note Rewrite, and Note Editing—to help users generate, refine, and proofread notes…
1 sourcenote.com -
Google DeepMind’s Hassabis and Dean step down amid AI industry shift
Google DeepMind’s leadership reshuffle signals a shift in AI’s focus from research breakthroughs to industrial-scale deployment. In August 2026, Demis Hassabis—co-founder of DeepMind and architect of AlphaGo and…
1 sourcenote.com
Questions about AlphaFold
What is the latest AlphaFold news?
As of 30 October 2026: Isomorphic Labs aims to design cancer drugs with AI, plans human trials soon. Google DeepMind spinoff Isomorphic Labs, led by CEO Demis Hassabis and President Max Jaderberg, is using its AlphaFold-derived drug design engine to develop novel cancer, immune, and inflammatory disease treatments.
What is AlphaFold?
AlphaFold is DeepMind’s AI system that predicts protein structures, having generated predictions for more than 200 million proteins and providing a large data foundation for drug‑discovery efforts. Recent coverage highlights its expansion into rare‑disease drug discovery, debates over its scientific limits, inclusion in a new Ohio State‑Google research hub, and industry data‑sharing initiatives aimed at improving protein‑folding models.